Treatment of melasma with the 1,927‐nm fractional thulium fiber laser: A retrospective analysis of 20 cases with long‐term follow‐up
Authors:
- Ane Beatriz M.AMAne Beatriz M.
- Sasima EimpunthSESasima Eimpunth
- Sabrina G. FabiSFSabrina G. Fabi
- Isabella GuihaIGIsabella Guiha
- William GroffWGWilliam Groff
- Richard FitzpatrickRFRichard Fitzpatrick
- 19 December 2012
- journal article
- research article
- Published by Wiley in Lasers in Surgery and Medicine
- Vol. 45 (2) , 95-101
Abstract
Background: Melasma is a common acquired symmetrical hyperpigmentation that is often recurrent and refractory.Objectives: To investigate the efficacy and safety of a single administration of high‐density fractional thulium fiber laser (1,927 nm) for the treatment of refractory melasma in 20 patients.Materials and Methods: A retrospective chart and photographs review of 20 women (Fitzpatrick skin type II–IV) with clinical diagnosis of melasma treated with the 1,927‐nm fractionated thulium laser at 10 or 20 mJ/cm2, with 60–70% surface area coverage. Four investigators independently evaluated Melasma Area Severity Index (MASI) scores before, 4 weeks, 3–6 months, and 6–12 months after treatment.Results: Mean MASI scores decreased dramatically from 13.2 ± 5.4 before treatment to 8.5 ± 3.5 at 4 weeks after laser treatment (P = 0.004). Patient assessment revealed that 12 of the 20 subjects had more than 50% clearance of their melasma. Recurrence was reported by 7 out of 15 patients who were successfully followed‐up (mean 10.2 months). Two patients developed postinflammatory hyperpigmentation that subsided with topical bleaching after 3 months.Conclusion: High‐density coverage fractional 1,927‐nm thulium laser proved to be safe and effective for melasma with long‐term remission. Lasers Surg. Med. 45: 95–101, 2013.Keywords
This publication has 33 references indexed in Scilit:
- 1,927-nm Fractional Thulium Fiber Laser for the Treatment of Nonfacial Photodamage: A Pilot StudyDermatologic Surgery, 2011
- Short-Sequence Oligopeptides with Inhibitory Activity against Mushroom and Human TyrosinaseJournal of Investigative Dermatology, 2009
- Effect of melasma on quality of life in a sample of women living in southern BrazilJournal of the European Academy of Dermatology and Venereology, 2008
- Therapeutical Approaches in MelasmaDermatologic Clinics, 2007
- A comparison of triple combination cream and hydroquinone 4% cream for the treatment of moderate to severe facial melasmaJournal of Cosmetic Dermatology, 2007
- The treatment of melasma: A review of clinical trialsJournal of the American Academy of Dermatology, 2006
- The dermal stem cell factor and c-kit are overexpressed in melasmaBritish Journal of Dermatology, 2006
- Tretinoin Peels versus Glycolic Acid Peels in the Treatment of Melasma in Dark-Skinned PatientsDermatologic Surgery, 2004
- Selective Photothermolysis: Precise Microsurgery by Selective Absorption of Pulsed RadiationScience, 1983
- Treatment of Melasma (Chloasma) by Local Application of a Steroid CreamDermatology, 1975